
Another green light for the nuclear comeback tour
Oklo just snagged startup authorization from the U.S. Department of Energy for its Groves Isotope Test Reactor, and that’s a pretty big deal in a business where paperwork can be as important as physics.
This approval completes the DOE’s authorization process for the reactor and clears the way for the next steps: fuel loading, startup testing, and eventually reactor operations. Translation: the project is moving from the "we have a plan" phase to the "let's see if this thing actually runs" phase.
Why investors care
For a company like Oklo, every regulatory win is a de-risking moment. It doesn’t mean revenue is suddenly exploding tomorrow, but it does mean the path to commercialization is getting a little less foggy.
That matters because investors aren’t just betting on a concept here — they’re betting on whether advanced nuclear can actually survive the jump from pitch deck to real infrastructure. And in that game, startup authorization is the kind of milestone that can keep the hype machine humming.
Big picture: nuclear stories tend to move in slow motion until they suddenly don’t. Today, Oklo looks a step closer to the "suddenly" part.
